BP

DEVICE4 trials

Sponsors

Glaxosmithkline Research & Development Limited, University of Warmia and Mazury, Activ'inside, Duke University

Conditions

Chronic Kidney DiseasesHealthyPainSystemic Lupus ErythematosusType 2 Diabetes

Phase 2

A Multi-center, Randomized Parallel Group, Placebo-Controlled Double-Blind Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of Belimumab, a Human Monoclonal Anti-BLyS Antibody, Plus Standard Therapy in Pediatric Patients with Systemic Lupus Erythematosus (SLE)

CompletedCTIS2024-512730-15-00

Glaxosmithkline Research & Development LimitedSystemic Lupus Erythematosus

Start: 2012-09-14End: 2025-06-02Target: 6Updated: 2024-11-22

Unknown Phase

Pupillometry - Future of Objective Pain Reaction Measurement While Unconscious

CompletedNCT04000126

University of Warmia and MazuryPain

Start: 2019-02-25End: 2019-12-31Updated: 2020-01-22

Bioavailabity of the Major Metabolites of a Botanical Extract, in Healthy Adults

CompletedNCT05098093

Activ'insideHealthy

Start: 2021-11-23End: 2022-03-21Updated: 2023-04-13

Improving Screening and Therapy for Hispanic/Latinx at Risk for CKD

CompletedNCT05734989

Duke UniversityChronic Kidney Diseases, Type 2 Diabetes

Start: 2023-05-18End: 2025-04-04Updated: 2025-04-20